Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Date RFP Issued: September 9, 2026
Geographic Scope: United States and Europe are the priority regions although proposals with global reach are encouraged
Clinical Area: Oncology - Genitourinary
Link to full RFP: New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Application Due Date: October 21, 2026
Specific Area of Interest: Projects that will be considered for Pfizer support will focus on increasing healthcare professional awareness and understanding in the following areas:
- differentiated mechanism of action (MOA) of emerging therapies including EZH2 inhibition and its possible role in prostate cancer
- EZH2 and other novel mechanisms of disease (MOD) and their role in prostate cancer progression
- the investigational thesis of how concomitant EZH2 and AR inhibition may suppress prostate cancer while delaying or overcoming ARPi resistance
- the continued unmet need for novel therapies in mCRPC
- mCRPC therapies beyond chemotherapy
- ongoing clinical trials that may be an option for patients today